drugset / Trial / NCT00003884
Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
RandomizedSupportive care
Summary
RATIONALE: Zoledronate may help to relieve some of the symptoms caused by bone metastases. It is not yet known if zoledronate is more effective than no further therapy in relieving symptoms of bone metastases or preventing disease progression. PURPOSE: Randomized phase III trial to determine the effectiveness of zoledronate in treating patients who have solid tumors that have spread to the bone.
Timeline
- Start
- 1998-08
- Primary completion
- 2001-01
- Completion
- 2001-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronic acid | Other / unclassified | 4 mg | Intravenous |
| Subject | Zoledronic acid | Other / unclassified | 8 mg | Intravenous |